Preoperative Versus Postoperative Chemotherapy With <scp>CAPOX</scp> Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase <scp>II</scp> Trial ( <scp>HiSCO</scp> ‐01)
Preoperative Versus Postoperative Chemotherapy With CAPOX Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase II Trial ( HiSCO ‐01)
Yuji Takakura, Naruhiko Honmyo, Hideki Ohdan, Takafumi Oshiro et al.
Citations
2 citations
Journal
Annals of Gastroenterological Surgery
Topics
Hepatocellular Carcinoma Treatment and Prognosis
Field-Weighted Citation Impact (FWCI)
2.64
article
Preoperative Versus Postoperative Chemotherapy With CAPOX Plus Bevacizumab for Resectable Colorectal Liver Metastases: A Randomized Phase II Trial ( HiSCO ‐01)
Hiroshima University (JP), Hiroshima General Hospital (JP), Hiroshima City Asa Citizens Hospital (JP), Hiroshima Prefectural Hospital (JP), Higashihiroshima Medical Center (JP), Chugoku Rosai Hospital (JP), National Hospital Organization (JP), Kure Medical Center (JP), Onomichi General Hospital (JP)